• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amesite Inc. filed SEC Form 8-K: Regulation FD Disclosure

    2/19/25 4:30:15 PM ET
    $AMST
    Computer Software: Prepackaged Software
    Technology
    Get the next $AMST alert in real time by email
    false 0001807166 0001807166 2025-02-18 2025-02-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

      

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): February 18, 2025

    Amesite Inc.

    (Exact name of registrant as specified in its charter)

     

     Delaware   001-39553   82-3431718

    (State or other jurisdiction

    of incorporation)

      (Commission File Number)  

    (IRS Employer

    Identification No.)

     

    607 Shelby Street

    Suite 700 PMB 214

    Detroit,MI

      48226
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (734) 876-8130

     

    N/A

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $0.0001 per share   AMST   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

      

     

     

     


    Item 7.01 Regulation FD Disclosure.

     

    On February 18, 2025, Amesite Inc. (the “Company”) released a new corporate introductory video, including details about the Company’s recently launched mobile healthcare app, NurseMagic. The video is available on the Company’s newly redesigned website at https://www.amesite.com.

     

    The information in this Item 7.0 of this Current Report on Form 8-K are furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in this Item 7.01 of this Current Report on Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in any such filing.

     

     

     

     

    SIGNATURES 

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      AMESITE INC.
         
    Date: February 19, 2025 By: /s/ Ann Marie Sastry, Ph.D.
        Ann Marie Sastry, Ph.D.
        Chief Executive Officer

     

    Get the next $AMST alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMST

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AMST
    SEC Filings

    See more
    • Amesite Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Amesite Inc. (0001807166) (Filer)

      5/16/25 4:15:35 PM ET
      $AMST
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 10-Q filed by Amesite Inc.

      10-Q - Amesite Inc. (0001807166) (Filer)

      5/15/25 4:40:08 PM ET
      $AMST
      Computer Software: Prepackaged Software
      Technology
    • Amesite Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - Amesite Inc. (0001807166) (Filer)

      2/19/25 4:30:15 PM ET
      $AMST
      Computer Software: Prepackaged Software
      Technology